Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share - Narrative (Details)

v3.22.1
Loss Per Share - Narrative (Details) - $ / shares
3 Months Ended
Jun. 17, 2021
Aug. 13, 2020
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Anti-dilutive employee share-based awards, excluded     0 0  
Common stock, shares outstanding (in shares)     18,750,000    
Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of trading days for determining the value per share 20 days 20 days 20 days    
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of trading days for determining the value per share 30 days 30 days 30 days    
Share-based Payment Arrangement, Tranche One          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted average grant-date fair value, granted (dollars per share)     $ 12.00    
Share-based Payment Arrangement, Tranche Two          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted average grant-date fair value, granted (dollars per share)     14.00    
Share-based Payment Arrangement, Tranche Three          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted average grant-date fair value, granted (dollars per share)     $ 16.00    
Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Class of warrant or right outstanding (in shares)     27,249,879    
Warrant exercise price (in dollars per share)     $ 11.50    
Common stock, shares outstanding (in shares)   18,750,000 199,523,392   199,523,292